Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm

per Issa, Ghayas C., DiNardo, Courtney D.
Publicat a Blood Cancer J (2021)

Novel agents in Waldenström macroglobulinemia

per Issa, Ghayas C, Ghobrial, Irene M, Roccaro, Aldo M
Publicat 2011

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

per Zarka, Jabra, Short, Nicholas J., Kanagal-Shamanna, Rashmi, Issa, Ghayas C.
Publicat a Genes (Basel) (2020)

Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology

per Sacco, Antonio, Issa, Ghayas C, Zhang, Yong, Liu, Yang, Maiso, Patricia, Ghobrial, Irene M, Roccaro, Aldo M
Publicat 2010

Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

per Short, Nicholas J., Jabbour, Elias, Sasaki, Koji, Patel, Keyur, O’Brien, Susan M., Cortes, Jorge E., Garris, Rebecca, Issa, Ghayas C., Garcia-Manero, Guillermo, Luthra, Rajyalakshmi, Thomas, Deborah, Kantarjian, Hagop, Ravandi, Farhad
Publicat a Blood (2016)

NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated AML

per Abbas, Hussein A., Ravandi, Farhad, Loghavi, Sanam, Patel, Keyur P., Borthakur, Gautam, Kadia, Tapan M., Jabbour, Elias, Takahashi, Koichi, Cortes, Jorge, Issa, Ghayas C., Konopleva, Marina, Kantarjian, Hagop M., Short, Nicholas J.
Publicat a Am J Hematol (2019)

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

per Alotaibi, Ahmad S., Yilmaz, Musa, Loghavi, Sanam, DiNardo, Courtney, Borthakur, Gautam, Kadia, Tapan M., Thakral, Beenu, Pemmaraju, Naveen, Issa, Ghayas C., Konopleva, Marina, Short, Nicholas J., Patel, Keyur, Tang, Guilin, Ravandi, Farhad, Daver, Naval
Publicat a Front Oncol (2020)

Hyper-CVAD + ponatinib vs. hyper-CVAD + dasatinib as frontline therapy for Ph-positive ALL: a propensity score analysis

per Sasaki, Koji, Jabbour, Elias, Ravandi, Farhad, Short, Nicholas J., Thomas, Deborah, Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Issa, Ghayas C., Jeanis, Vicki, Moore, Gal, Garris, Rebecca, Pemmaraju, Naveen, Cortes, Jorge E., O'Brien, Susan, Kantarjian, Hagop
Publicat a Cancer (2016)

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

per Chamoun, Kamal, Kantarjian, Hagop, Atallah, Rami, Gonzalez, Graciela Nogueras, Issa, Ghayas C., Rios, Mary Beth, Garcia-Manero, Guillermo, Borthakur, Gautam, Ravandi, Farhad, Jain, Nitin, Daver, Naval, Konopleva, Marina, DiNardo, Courtney D., Kadia, Tapan, Pemmaraju, Naveen, Jabbour, Elias, Cortes, Jorge
Publicat a J Hematol Oncol (2019)

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid...

per Abou Dalle, Iman, Ghorab, Ahmad, Patel, Keyur, Wang, Xuemei, Hwang, Hyunsoo, Cortes, Jorge, Issa, Ghayas C., Yalniz, Fevzi, Sasaki, Koji, Chihara, Dai, Price, Allyson, Kadia, Tapan, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney, Ravandi, Farhad, Kantarjian, Hagop M., Borthakur, Gautam
Publicat a Blood Cancer J (2020)

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment

per Issa, Ghayas C., Kantarjian, Hagop M., Gonzalez, Graciela Nogueras, Borthakur, Gautam, Tang, Guilin, Wierda, William, Sasaki, Koji, Short, Nicholas J., Ravandi, Farhad, Kadia, Tapan, Patel, Keyur, Luthra, Raja, Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Rios, Mary Beth, Dellasala, Sara, Jabbour, Elias, Cortes, Jorge E.
Publicat a Blood (2017)

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab vs. Standard Intensive Chemotherapy (hyper-CVAD) as Frontline The...

per Jabbour, Elias, Sasaki, Koji, Ravandi, Farhad, Short, Nicholas J., Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Cortes, Jorge, Issa, Ghayas C., Jacob, Jovitta, Kwari, Monica, Thompson, Philip, Garris, Rebecca, Pemmaraju, Naveen, Yilmaz, Musa, O’Brien, Susan, Kantarjian, Hagop
Publicat a Cancer (2019)

Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype

per Samra, Bachar, Richard-Carpentier, Guillaume, Kadia, Tapan M., Ravandi, Farhad, Daver, Naval, DiNardo, Courtney D., Issa, Ghayas C., Bose, Prithviraj, Konopleva, Marina Y., Yilmaz, Musa, Ohanian, Maro, Borthakur, Gautam, Garcia-Manero, Guillermo, Pierce, Sherry, Cortes, Jorge E., Kantarjian, Hagop, Short, Nicholas J.
Publicat a Blood Cancer J (2020)

Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

per Short, Nicholas J., Rafei, Hind, Daver, Naval, Hwang, Hyunsoo, Ning, Jing, Jorgensen, Jeffrey L., Kadia, Tapan M., DiNardo, Courtney D., Wang, Sa A., Jabbour, Elias, Popat, Uday, Oran, Betul, Cortes, Jorge, Konopleva, Marina, Yilmaz, Musa, Issa, Ghayas C., Kantarjian, Hagop, Ravandi, Farhad
Publicat a Blood Adv (2020)

Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

per Short, Nicholas J., Montalban-Bravo, Guillermo, Hwang, Hyunsoo, Ning, Jing, Franquiz, Miguel J., Kanagal-Shamanna, Rashmi, Patel, Keyur P., DiNardo, Courtney D., Ravandi, Farhad, Garcia-Manero, Guillermo, Takahashi, Koichi, Konopleva, Marina, Daver, Naval, Issa, Ghayas C., Andreeff, Michael, Kantarjian, Hagop, Kadia, Tapan M.
Publicat a Blood Adv (2020)

Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative ALL

per Short, Nicholas J., Kantarjian, Hagop, Sasaki, Koji, Cortes, Jorge E., Ravandi, Farhad, Thomas, Deborah, Garcia-Manero, Guillermo, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, Issa, Ghayas C., Konopleva, Marina, Kadia, Tapan M., Bueso-Ramos, Carlos, Khoury, Joseph D., Jain, Nitin, O’Brien, Susan M., Jabbour, Elias
Publicat a Cancer (2016)

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

per Short, Nicholas J., Patel, Keyur P., Albitar, Maher, Franquiz, Miguel, Luthra, Rajyalakshmi, Kanagal-Shamanna, Rashmi, Wang, Feng, Assi, Rita, Montalban-Bravo, Guillermo, Matthews, Jairo, Ma, Wanlong, Loghavi, Sanam, Takahashi, Koichi, Issa, Ghayas C., Kornblau, Steven M., Jabbour, Elias, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Estrov, Zeev, Ravandi, Farhad
Publicat a Blood Adv (2020)

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL

per Short, Nicholas J., Kantarjian, Hagop, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Ravandi, Farhad, Cortes, Jorge, Konopleva, Marina, Issa, Ghayas C., Kornblau, Steven M., Garcia-Manero, Guillermo, Garris, Rebecca, Higgins, Jake, Pratt, Gabriel, Williams, Lindsey N., Valentine, Charles C., Rivera, Victor M., Pritchard, Justin, Salk, Jesse J., Radich, Jerald, Jabbour, Elias
Publicat a Blood Cancer J (2020)

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative ALL in the era of MRD

per Issa, Ghayas C., Kantarjian, Hagop, Yin, C. Cameron, Qiao, Wei, Ravandi, Farhad, Thomas, Deborah, Short, Nicholas J., Sasaki, Koji, Garcia-Manero, Guillermo, Kadia, Tapan M., Cortes, Jorge E., Daver, Naval, Borthakur, Gautam, Jain, Nitin, Konopleva, Marina, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, O'Brien, Susan M., Jabbour, Elias
Publicat a Cancer (2016)

Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase...

per Short, Nicholas J., Kantarjian, Hagop M., Sasaki, Koji, Ravandi, Farhad, Ko, Heidi, Yin, C. Cameron, Garcia-Manero, Guillermo, Cortes, Jorge E., Garris, Rebecca, O'Brien, Susan M., Patel, Keyur, Khouri, Maria, Thomas, Deborah, Jain, Nitin, Kadia, Tapan M., Daver, Naval, Benton, Christopher B., Issa, Ghayas C., Konopleva, Marina, Jabbour, Elias
Publicat a Am J Hematol (2017)